← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Autoimmune Technologies, Llc
New Orleans, LA
$20,618,419
Total funding
7
Grants
Funding over time
peak $6.3M · FY2006–18$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$20,378,516 · 6
DOD$239,903 · 1
By mechanism
N01$14,967,446 · 1
R44$3,938,686 · 1
R41$1,247,384 · 3
—$239,903 · 1
R43$225,000 · 1
Investigators at Autoimmune Technologies, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES$6,071,737
N01 · FY2014 · AI
DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES$4,703,944
N01 · FY2015 · AI
DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES$4,191,765
N01 · FY2016 · AI
Peptide inhbitors of influenza entry-FAST TRACK$1,328,888
R44 · FY2011 · AI
Peptide inhbitors of influenza entry-FAST TRACK$1,305,089
R44 · FY2010 · AI
Peptide inhbitors of influenza entry-FAST TRACK$1,304,709
R44 · FY2009 · AI
Peptide drugs against influenza virus$461,944
R41 · FY2007 · AI
Peptide drugs against influenza virus$460,957
R41 · FY2006 · AI
DEVELOPMENT OF AN IMMUNOTHERAPEUTIC DELIVERY PLATFORM USING ADIPOSE-DERIVED MESENCHYMAL STEM CELLS$239,903
· FY2017 · Department of the Army
Peptide inhibitors of coronavirus entry$225,000
R43 · FY2014 · AI
Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species$224,645
R41 · FY2018 · AI
Development of molecular diagnostic assays for systemic autoimmune diseases$99,838
R41 · FY2006 · AI